What's breaking now, across thousands of outlets.
Amgen reported a key clinical win for its T cell engager platform, finding that Imdelltra combined with a checkpoint inhibitor helped patients with advanced lung cancer live longer. The California pharma company
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
"In many cases, these devices are better suited to tracking trends over time, rather than as precise laboratory measurements."
An expert shares guidance to help owners better understand changes in their pets' behavior and learn how to care for animals living with dementia.
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals at its facility. It also included photos.
Rather than requiring genetic modification of the viral glycoprotein, G-Link uses a modular protein adaptor to blind native VSV-G tropism and redirect delivery after vector production.
A team from the Research Institute of the McGill University Health Center (The Institute) have created a three-dimensional, beating heart-on-a-chip, or "mini-heart," using blood cells from a patient…
Researchers found that altering a small group of dopamine-producing neurons in fruit flies fragments their sleep. This sleep deprivation prevents the insects from forming long-term memories, highlighting a crucial neural link between rest and learning.
